We are live on ! Find out more
NC

Nitorum Capital Portfolio holdings

AUM $114M
1-Year Est. Return 17.21%
This Fund
S&P 500
This Quarter Est. Return
-10.69%
1 Year Est. Return
+17.21%
3 Year Est. Return
+55.08%
5 Year Est. Return
+47.13%
10 Year Est. Return
+329.47%
AUM
$1.51B
AUM Growth
-$624M
Cap. Flow
-$440M
Cap. Flow %
-29.18%
Top 10 Hldgs %
56.44%
Holding
39
New
1
Increased
5
Reduced
16
Closed
6

Top Buys

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$69.2M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$66.6M
3
PYPL icon
PayPal
PYPL
+$26.8M
4
MSM icon
MSC Industrial Direct
MSM
+$17.2M
5
EVR icon
Evercore
EVR
+$8.79M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.16%
2 Financials 15.7%
3 Healthcare 14.74%
4 Industrials 12.48%
5 Technology 10.04%

Similar funds

Nitorum Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Nitorum Capital held 39 positions worth $1.51B, down 29% from $2.13B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nitorum Capital withdrew a net $440M in Q1 2022, closing 6 positions and reducing 16 holdings. Its most notable exit was Dun & Bradstreet, an estimated $49.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 30% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Nitorum Capital opened a new position in Bio-Rad Laboratories Class A worth $62.3M.

  • Nitorum Capital's largest Q1 2022 buy was Bio-Rad Laboratories Class A: 110,557 shares worth $62.3M.
  • Nitorum Capital added most to Azenta in Q1 2022, an estimated $69.2M increase.
  • Nitorum Capital's biggest Q1 2022 reduction was Cerner Corp, cutting an estimated $71.6M.
  • Nitorum Capital fully exited Dun & Bradstreet in Q1 2022, selling an estimated $49.5M.
  • Nitorum Capital's ten largest holdings make up 56% of its $1.51B portfolio in Q1 2022.
  • Nitorum Capital opened 1 new position and closed 6 in Q1 2022.
  • Nitorum Capital's portfolio value fell 29% quarter-over-quarter to $1.51B.

Based on Nitorum Capital's 13F filing for Q1 2022, filed 16 May 2022.